Superinduction of IL-6 by cycloheximide is associated with mRNA stabilization and sustained activation of p38 map kinase and NF-κB in cultured Caco-2 cells

Dan D. Hershko, Bruce Robb, Curtis J. Wray, Guan Ju Luo, Per Olof Hasselgren

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Protein synthesis inhibitors paradoxically increase the expression of early-gene products, including various cytokines, through a process known as superinduction. Superinduction is cell-specific and the mechanisms involved are not fully understood but are usually attributed to decreased mRNAdegradation. There is, however, increasing evidence that activation of signaling cascades and increased transcriptional activation may be involved as well. Recent studies suggest that IL-6 production in the intestinal mucosa is particularly important due to its anti-inflammatory and protective effects. The effect of protein synthesis inhibitors on IL-6 production in enterocytes, however, is unknown. Treatment of Caco-2 cells with cycloheximide (10 μg/ml) increased IL-6 mRNA and protein levels in IL-1 β-treated cells and this was associated with increased mRNA stabilization. In addition, cycloheximide suppressed IκBα resynthesis and prolonged p38MAP kinase activation and these changes were associated with sustained activation of the transcription factor NF-κB. NF-κB activation, in turn, was prevented by the specific p38MAP kinase inhibitor SB208350. Our results suggest that superinduction of IL-6 by cycloheximide in enterocytes results from both increased mRNA stabilization and upregulated transcriptional activity mediated by prolonged activation of the p38 MAP kinase and NF-κB.

Original languageEnglish (US)
Pages (from-to)951-961
Number of pages11
JournalJournal of Cellular Biochemistry
Volume91
Issue number5
DOIs
StatePublished - 2004
Externally publishedYes

Fingerprint

Caco-2 Cells
Cycloheximide
Cultured Cells
Interleukin-6
Phosphotransferases
Stabilization
Chemical activation
Messenger RNA
Protein Synthesis Inhibitors
Enterocytes
p38 Mitogen-Activated Protein Kinases
Intestinal Mucosa
Interleukin-1
Transcriptional Activation
Anti-Inflammatory Agents
Transcription Factors
Cytokines
Gene Expression
Genes
Cells

Keywords

  • Cell signaling
  • Cytokines
  • Enterocytes
  • Protein synthesis inhibitors
  • Transcription factors

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology

Cite this

Superinduction of IL-6 by cycloheximide is associated with mRNA stabilization and sustained activation of p38 map kinase and NF-κB in cultured Caco-2 cells. / Hershko, Dan D.; Robb, Bruce; Wray, Curtis J.; Luo, Guan Ju; Hasselgren, Per Olof.

In: Journal of Cellular Biochemistry, Vol. 91, No. 5, 2004, p. 951-961.

Research output: Contribution to journalArticle

@article{124ad812444c4fab99529e00242d6439,
title = "Superinduction of IL-6 by cycloheximide is associated with mRNA stabilization and sustained activation of p38 map kinase and NF-κB in cultured Caco-2 cells",
abstract = "Protein synthesis inhibitors paradoxically increase the expression of early-gene products, including various cytokines, through a process known as superinduction. Superinduction is cell-specific and the mechanisms involved are not fully understood but are usually attributed to decreased mRNAdegradation. There is, however, increasing evidence that activation of signaling cascades and increased transcriptional activation may be involved as well. Recent studies suggest that IL-6 production in the intestinal mucosa is particularly important due to its anti-inflammatory and protective effects. The effect of protein synthesis inhibitors on IL-6 production in enterocytes, however, is unknown. Treatment of Caco-2 cells with cycloheximide (10 μg/ml) increased IL-6 mRNA and protein levels in IL-1 β-treated cells and this was associated with increased mRNA stabilization. In addition, cycloheximide suppressed IκBα resynthesis and prolonged p38MAP kinase activation and these changes were associated with sustained activation of the transcription factor NF-κB. NF-κB activation, in turn, was prevented by the specific p38MAP kinase inhibitor SB208350. Our results suggest that superinduction of IL-6 by cycloheximide in enterocytes results from both increased mRNA stabilization and upregulated transcriptional activity mediated by prolonged activation of the p38 MAP kinase and NF-κB.",
keywords = "Cell signaling, Cytokines, Enterocytes, Protein synthesis inhibitors, Transcription factors",
author = "Hershko, {Dan D.} and Bruce Robb and Wray, {Curtis J.} and Luo, {Guan Ju} and Hasselgren, {Per Olof}",
year = "2004",
doi = "10.1002/jcb.20014",
language = "English (US)",
volume = "91",
pages = "951--961",
journal = "Journal of Cellular Biochemistry",
issn = "0730-2312",
publisher = "Wiley-Liss Inc.",
number = "5",

}

TY - JOUR

T1 - Superinduction of IL-6 by cycloheximide is associated with mRNA stabilization and sustained activation of p38 map kinase and NF-κB in cultured Caco-2 cells

AU - Hershko, Dan D.

AU - Robb, Bruce

AU - Wray, Curtis J.

AU - Luo, Guan Ju

AU - Hasselgren, Per Olof

PY - 2004

Y1 - 2004

N2 - Protein synthesis inhibitors paradoxically increase the expression of early-gene products, including various cytokines, through a process known as superinduction. Superinduction is cell-specific and the mechanisms involved are not fully understood but are usually attributed to decreased mRNAdegradation. There is, however, increasing evidence that activation of signaling cascades and increased transcriptional activation may be involved as well. Recent studies suggest that IL-6 production in the intestinal mucosa is particularly important due to its anti-inflammatory and protective effects. The effect of protein synthesis inhibitors on IL-6 production in enterocytes, however, is unknown. Treatment of Caco-2 cells with cycloheximide (10 μg/ml) increased IL-6 mRNA and protein levels in IL-1 β-treated cells and this was associated with increased mRNA stabilization. In addition, cycloheximide suppressed IκBα resynthesis and prolonged p38MAP kinase activation and these changes were associated with sustained activation of the transcription factor NF-κB. NF-κB activation, in turn, was prevented by the specific p38MAP kinase inhibitor SB208350. Our results suggest that superinduction of IL-6 by cycloheximide in enterocytes results from both increased mRNA stabilization and upregulated transcriptional activity mediated by prolonged activation of the p38 MAP kinase and NF-κB.

AB - Protein synthesis inhibitors paradoxically increase the expression of early-gene products, including various cytokines, through a process known as superinduction. Superinduction is cell-specific and the mechanisms involved are not fully understood but are usually attributed to decreased mRNAdegradation. There is, however, increasing evidence that activation of signaling cascades and increased transcriptional activation may be involved as well. Recent studies suggest that IL-6 production in the intestinal mucosa is particularly important due to its anti-inflammatory and protective effects. The effect of protein synthesis inhibitors on IL-6 production in enterocytes, however, is unknown. Treatment of Caco-2 cells with cycloheximide (10 μg/ml) increased IL-6 mRNA and protein levels in IL-1 β-treated cells and this was associated with increased mRNA stabilization. In addition, cycloheximide suppressed IκBα resynthesis and prolonged p38MAP kinase activation and these changes were associated with sustained activation of the transcription factor NF-κB. NF-κB activation, in turn, was prevented by the specific p38MAP kinase inhibitor SB208350. Our results suggest that superinduction of IL-6 by cycloheximide in enterocytes results from both increased mRNA stabilization and upregulated transcriptional activity mediated by prolonged activation of the p38 MAP kinase and NF-κB.

KW - Cell signaling

KW - Cytokines

KW - Enterocytes

KW - Protein synthesis inhibitors

KW - Transcription factors

UR - http://www.scopus.com/inward/record.url?scp=16644383740&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=16644383740&partnerID=8YFLogxK

U2 - 10.1002/jcb.20014

DO - 10.1002/jcb.20014

M3 - Article

VL - 91

SP - 951

EP - 961

JO - Journal of Cellular Biochemistry

JF - Journal of Cellular Biochemistry

SN - 0730-2312

IS - 5

ER -